Treating Acute Urinary Tract Infection in Postmenopausal Women
Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.
Urinary Tract Infections
Urinary Tract Infections
Latest News
Multiple-Dose Fosfomycin for Complicated UTIs
In cases of complicated urinary tract infections (UTI) treated with multiple-dose fosfomycin, clinical resolution occurred in 2 of 3 treatment episodes.
Novel Cephalosporin Now Available for Treatment of Complicated UTI
Fetroja® (cefiderocol) has been made available by Shionogi for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.
UTI Recurrence in Pediatric Patients: Antibiotic Treatment Duration Examined
In pediatric patients, the duration of antibiotic treatment for uncomplicated UTI was not significantly associated with UTI recurrence.
Vegetarian Diet Linked to Lower Risk for Urinary Tract Infection
A vegetarian diet is associated with a reduced risk for urinary tract infection.
Cefiderocol Approved for Complicated UTI in Patients With Limited or No Alternative Treatment Options
The FDA has approved Fetroja for the treatment of complicated urinary tract infections.
UTI Antibiotic Use to be Improved in Nursing Homes
Enhanced implementation on adoption of evidence-based antibiotic stewardship in nursing homes focused on the recognition and management of UTIs may improve the quality of antibiotic prescription in nursing homes.
Updated Algorithm Improves Specificity of UTI Detection in Patients With Relapsing Multiple Sclerosis
With an improved specificity, an updated algorithm for the detection of UTIs in patients with relapsing MS addresses previous issues concerning the unnecessary prescription of antibiotics, whilst improving accuracy and maintaining safety.
Cefoxitin Is Efficacious in Treatment of Febrile Urinary Tract Infection in Men
A high dose and continuous infusion of cefoxitin has been associated with clinical success in treating febrile urinary tract infections in men caused by extended spectrum beta-lactamase–producing E coli.
FDA Panel Votes on Novel Antibiotic for Complicated UTI
The FDA’s Antimicrobial Drugs Advisory Committee voted in favor of approval of cefiderocol for the treatment of complicated UTIs including pyelonephritis.
Comparison of Antibiotic Activity in Complicated UTI From Gram-Negative Bacteria
Ceftazidime-avibactam was highly active against a large collection of gram-negative bacteria isolated from patients with complicated urinary tract infections.
USPSTF Urges Asymptomatic Bacteriuria Screening in Pregnancy
No net benefit seen for screening, treatment of asymptomatic bacteriuria for nonpregnant adults
Risk Factors for Community-Acquired UTI With ESBL-Producing E coli in Children
Antibiotic use within the previous 3 months and Middle Eastern ethnic background were risk factors for community-acquired urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in children treated at the Children’s Hospital of Michigan, according to study results published in Infectious Diseases. In this single center retrospective study, researchers identified 111 cases…
Suboptimal Adherence to Guidelines for Urine Cultures Orders in Patients With Catheters
Healthcare professionals may inappropriately order urine cultures for patients with catheters, on the basis of subjective signs rather than evidence-based guidelines.
Most UK Patients With UTI Receive Antibiotics on Same Day
Represcription rate at 28 days only 4.1 percent from 2011 to 2015; slight increase seen for men over time
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Initiation of therapy with SGLT-2 inhibitors for T2D mellitus is not associated with an increased risk for UTI events compared with initiation of other second-line antidiabetic medications.
Imipenem, Cilastatin, Relebactam Combination Approved To Treat Complicated UTI, Intra-Abdominal Infections
The FDA has approved Recarbrio for the treatment of adult patients aged 18 years and older with complicated UTI.
Infections Tied to Subsequent Risk for Acute Ischemic Stroke
Different infection types, especially UTI, are associated with subsequent acute ischemic stroke.
Pathogens in Uncomplicated UTI Commonly Resistant to Empiric Treatment
A significant percentage of patients with uncomplicated urinary tract infection (UTI) are treated with an empiric antibiotic agent to which the etiologic bacteria is resistant.
Fosfomycin for Injection: ZEUS Study Updates
Fosfomycin for injection may show promise and noninferiority compared with standard treatment for complicated urinary tract infections.
Probiotics More Effective Than Placebo for Reducing Recurrent UTI Risk
For children with a normal urinary tract, probiotics were more effective than placebo at reducing the risk for UTI after the first episode of a febrile UTI.
Want to read more?
Please login or register first to view this content.
Next post in Urinary Tract Infections
